Ken Griffin Dario Health Corp. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.78 - $1.45 $53,040 - $98,600	68,000 Added 187.33%	104,300 $116,000
Q2 2024 Aug 14, 2024	BUY	$1.09 - $1.9 $3,052 - $5,320	2,800 Added 8.36%	36,300 $43,000
Q1 2024 May 15, 2024	BUY	$1.4 - $2.55 $44,940 - $81,855	32,100 Added 2292.86%	33,500 $51,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $3.39 $5,300 - $17,967	-5,300 Reduced 79.1%	1,400 $2,000
Q3 2023 Nov 14, 2023	SELL	$2.6 - $4.23 $13,780 - $22,419	-5,300 Reduced 44.17%	6,700 $21,000
Q2 2023 Aug 14, 2023	BUY	$3.2 - $4.33 $31,680 - $42,867	9,900 Added 471.43%	12,000 $48,000
Q1 2023 May 15, 2023	SELL	$3.79 - $6.22 $259,994 - $426,692	-68,600 Reduced 97.03%	2,100 $8,000
Q4 2022 Feb 14, 2023	SELL	$3.53 - $5.49 $111,548 - $173,484	-31,600 Reduced 30.89%	70,700 $302,000
Q3 2022 Nov 14, 2022	BUY	$3.74 - $7.09 $303,688 - $575,708	81,200 Added 384.83%	102,300 $474,000

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $18.6M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.